Corporate America’s Real Worries About Trump Are Buried in Annual Reports bloomberg.com/news/articles/…

Lilly Cuts Price of Zepbound Vials to Battle Cheaper Copycats bloomberg.com/news/articles/…

As Measles Cases Surge in Texas, WHO’s Global Control Program Risks Collapse bloomberg.com/news/articles/…

Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine bloomberg.com/news/articles/… $mrna

Moves by Musk's DOGE this week have put the fate of a key lab that oversees US pharmaceutical safety in limbo. This raises questions about the Trump administration’s approach to expensive but crucial research that aims to keep America’s drug supply safe. bloomberg.com/news/articles/…

Trump’s CDC Pick Is Still Pushing Vaccine-Autism ‘Lie,’ Senator Says bloomberg.com/news/articles/…

White House Pulls CDC Pick Who Was Facing Likely Senate Defeat bloomberg.com/news/articles/…

New: At least seven people have died in the US from symptoms linked to a new Alzheimer's drug over the past two years. Regulators and doctors are divided over the risks. Story w/ Robert Langreth bloomberg.com/news/features/…

Americans’ Access to Lifesaving Vaccines Threatened by RFK Jr. Overhaul bloomberg.com/news/articles/…

RFK Jr. Is Scaring Parents Into Asking Doctors for Early Shots bloomberg.com/news/articles/…

Pro-Trump Urologist Appointed as Top Adviser to CDC Director bloomberg.com/news/articles/…

FDA to Share Rejection Letters Drugmakers Often Keep Secret bloomberg.com/news/articles/…

FDA Offers to Trade Faster Drug Reviews for Lower US Prices bloomberg.com/news/articles/…

Chinese drugmakers have come a long way from their copycat days to challenge Western dominance on innovation. Our latest story visualizes this stunning advance, with data from Norstella with Jinshan Hong and Spe Chen 陳羽萱: bloomberg.com/news/features/…

UnitedHealth quietly sold businesses to private equity firms at the end of last year to avoid missing Wall Street earnings targets. Read my story with Zachary Mider Ike Swetlitz John Tozzi for details about the deals & the unusual accounting decision here $UNH bloomberg.com/news/features/…

Wall Street Worries a Health Insurance Meltdown Is Far From Over bloomberg.com/news/articles/…

RFK Jr. Turns to Fringe Medical Journal to Find New Hires bloomberg.com/news/articles/…

New: A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales platforms, one week after President Donald Trump demanded that drugmakers create similar systems. (Gift link) bloomberg.com/news/articles/…

How did generic drug that alleviates cancer therapy side effects end up being touted as a treatment for autism? An FDA leader asked. Lizzy Lawrence has a stunning story on the political pressure inside the FDA to approve the drug as an autism treatment: statnews.com/2025/10/14/fda…